Lukang Pharmaceutical (600789.SH): Vancomycin hydrochloride for injection is to be selected for centralized procurement nationwide

Zhitong Finance App News, Lu Kong Pharmaceutical (600789.SH) issued an announcement. Recently, the company participated in the bidding process for the 12th batch of centralized national drug procurement organized by the State Drug Joint Procurement Office. The company's product vancomycin hydrochloride for injection (0.5g (500,000 units)) will be selected for this centralized procurement.

This centralized procurement is the 12th batch of centralized drug procurement organized by the state. In terms of implementation, medical institutions across the country are required to prioritize the use of selected varieties from centralized procurement and ensure that the agreed procurement volume is completed. If the company subsequently signs a procurement contract and implements it, it will help expand sales of related products, increase market share, enhance the company's brand influence, and promote the further development of the company's formulation business.